TC1 Treatment resistant psychosis 1

Date: Monday 20 June
Time: 13.55 - 15.10
Stream: Psychopharmacology


Prof Oliver Howes will open the session with an overview of treatment resistance in psychiatry, considering its conceptualisation, its epidemiology, its impact, and some common neurobiological models. He will provide a structure to address treatment resistance, including research avenues to enable targeted and personalised therapeutic approaches. He will also present health and care outcomes from a secondary care treatment resistant psychosis service. · Prof James MacCabe will present his latest data on the factors influencing outcomes and continuation in people taking clozapine · Prof Mitul Mehta will talk to us about his work in Experimental Medicine – offering hope for the future of psychosis. Experimental medicine has the potential to provide causal evidence for biological theories and de-risk drug development, but is rarely deployed in psychiatry. This talk will demonstrate where experimental medicine models have been successful and highlight major challenges for this approach in psychiatry. 

Chair: Professor Fiona Gaughran, South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, Psychology and Neuroscience, King's College London

Treatment resistance in psychiatry

Professor Oliver Howes, Institute of Psychiatry, Psychology and Neuroscience, King's College London and South London and Maudsley NHS Foundation Trust

Should we prescribe clozapine in children?

Professor James MacCabe, National Psychosis Unit, South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience, King's College London

Experimental medicine models in psychosis

Professor Mitul Mehta, Institute of Psychiatry, Psychology and Neuroscience, King's College London

Speakers

Please email congress@rcpsych.ac.uk or call 020 8618 4120 with any enquiries.